Seer, Inc. reported revenue of $4.0 million for the third quarter of 2024, a 3% decrease compared to the prior year. The company's net loss was $21.3 million. They ended the quarter with approximately $312 million in cash, cash equivalents and investments.
Revenue for the third quarter of 2024 reached $4.0 million.
A co-marketing and sales agreement was established with Thermo Fisher Scientific.
The company invested $10.0 million in PrognomiQ’s Series D preferred stock financing.
Approximately 3.7 million shares of Seer Class A common stock were repurchased during the third quarter.
Seer continues to expect full year 2024 revenue to be in the range of $13 to $15 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance